Recurrent Esophageal Carcinoma Recruiting Phase 2 Trials for Relatlimab (DB14851)

Also known as: Oesophageal carcinoma recurrent / Recurrent Oesophageal Carcinoma / Oesophageal carcinoma site unspecified recurrent / Esophageal carcinoma site unspecified recurrent / Esophageal carcinoma recurrent